Antidiabetic and hypolipidemic activities of Curculigo latifolia fruit:Root extract in high fat fed diet and low dose STZ induced diabetic rats

Evidence-based Complementary and Alternative Medicine

Volumn 2013, Issue , 2013, Pages

  Ishak, Nur Akmal ^a   Ismail, Maznah ^a   Hamid, Muhajir ^a   Ahmad, Zalinah ^a   Abd Ghafar, Siti Aisyah ^a  

^a UNIVERSITY PUTRA MALAYSIA   (Malaysia)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; ADIPONECTIN RECEPTOR 1; ADIPONECTIN RECEPTOR 2; ALANINE AMINOTRANSFERASE; ANTIDIABETIC AGENT; ANTILIPEMIC AGENT; CREATININE; CURCULIGO LATIFOLIA EXTRACT; GAMMA GLUTAMYLTRANSFERASE; GLUCOSE; GLUCOSE TRANSPORTER 4; HIGH DENSITY LIPOPROTEIN; INSULIN; INSULIN RECEPTOR SUBSTRATE 1; LEPTIN; LOW DENSITY LIPOPROTEIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PLANT EXTRACT; SOMATOMEDIN C; TRIACYLGLYCEROL; TRIACYLGLYCEROL LIPASE; UNCLASSIFIED DRUG; UREA;

ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIDIABETIC ACTIVITY; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CURCULIGO; CURCULIGO LATIFOLIA; DIABETES MELLITUS; FRUIT; GENE CONTROL; GENE EXPRESSION; GLUCOSE METABOLISM; LIPID DIET; LIPID METABOLISM; MALE; MEDICINAL PLANT; MUSCLE TISSUE; NONHUMAN; NUCLEOTIDE SEQUENCE; PLANT ROOT; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; WEIGHT GAIN;

EID: 84878714652     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2013/601838     Document Type: Article

References (66)

1. Pareek H., Sharma S., Khajja B. S., Jain K., Jain G. C., Evaluation of hypoglycemic and anti-hyperglycemic potential of Tridax procumbens (Linn.). BMC Complementary and Alternative Medicine 2009 9, article 48 2-s2.0-71949119996 10.1186/1472-6882-9-48
2. Zheng X. K., Li Y. J., Zhang L., Feng W. S., Zhang X., Antihyperglycemic activity of Selaginella tamariscina (Beauv.) Spring. Journal of Ethnopharmacology 2011 133 2 531 537 2-s2.0-78651395097 10.1016/j.jep.2010.10. 028
3. Lebovitz H. E., Banerji M. A., Treatment of insulin resistance in diabetes mellitus. European Journal of Pharmacology 2004 490 1-3 135 146 2-s2.0-1842633862 10.1016/j.ejphar.2004.02.051 (Pubitemid 38482167)
4. Wang Y., Yu J., Zhang C., Li P., Zhao Y., Zhang M., Zhou P., Influence of flavonoids from Phellinus igniarius on sturgeon caviar: antioxidant effects and sensory characteristics. Food Chemistry 2012 131 2 206 210
5. Patel D. K., Kumar R., Laloo D., Hemalatha S., Diabetes mellitus: an overview on its pharmacological aspects and reported medicinal plants having antidiabetic activity. Asian Pacific Journal of Tropical Biomedcine 2012 4 3 411 420
6. Srinivasan K., Viswanad B., Asrat L., Kaul C. L., Ramarao P., Combination of high-fat diet-fed and low-dose streptozotocin-treated rat: a model for type 2 diabetes and pharmacological screening. Pharmacological Research 2005 52 4 313 320 2-s2.0-23844504364 10.1016/j.phrs.2005.05.004 (Pubitemid 41175991)
7. Prasad D. S., Kabir Z., Dash A. K., Das B. C., Abdominal obesity, an independent cardiovascular risk factor in Indian subcontinent: a clinico epidemiological evidence summary. Journal of Cardiovascular Disease Research 2011 32 2 199 205
8. Zheng X., Zhang L., Wang W., Wu Y., Zhang Q., Feng W., Anti-diabetic activity and potential mechanism of total flavonoids of Selaginella tamariscina (Beauv.) Spring in rats induced by high fat diet and low dose STZ. Journal of Ethnopharmacology 2012 137 3 662 668
9. Clee S. M., Attie A. D., The genetic landscape of type-2 diabetes in mice. Endocrinology Reviews 2006 28 2 48 83
10. Masiello P., Animal models of type-2 diabetes with reduced pancreatic β -cell mass. The International Journal of Biochemistry and Cell Biology 2006 38 9 873 893 (Pubitemid 43363418)
11. Mythili M. D., Vyas R., Akila G., Gunasekaran S., Effect of Streptozotocin on the ultrastructure of rat pancreatic islets. Microscopy Research and Technique 2004 63 5 274 281 2-s2.0-2542623001 10.1002/jemt.20039 (Pubitemid 38702356)
12. Shafrir E., Porte D., Sherwin R. S., Baron A., Diabetes in animals: contribution to the understanding of diabetes by study of its etiophatology in animal models. Diabetes Mellitus 2003 New York, NY, USA McGraw-Hill 231 255
13. Unger R. H., Clark G. O., Scherer P. E., Orci L., Lipid homeostasis, lipotoxicity and the metabolic syndrome. Biochimica et Biophysica Acta 2010 1801 3 209 214 2-s2.0-76049091112 10.1016/j.bbalip.2009.10.006
14. Zhang Y., Li X., Zou D., Liu W., Yang J., Zhu N., Huo L., Wang M., Hong J., Wu P., Ren G., Ning G., Treatment of type 2 diabetes and dyslipidemia with the natural plant alkaloid berberine. Journal of Clinical Endocrinology and Metabolism 2008 93 7 2559 2565 2-s2.0-47549100864 10.1210/jc.2007-2404 (Pubitemid 352008520)
15. Franconi F., Seghieri G., Canu S., Straface E., Campesi I., Malorni W., Are the available experimental models of type 2 diabetes appropriate for a gender perspective? Pharmacological Research 2008 57 1 6 18 2-s2.0-39149104626 10.1016/j.phrs.2007.11.007
16. Sahin K., Onderci M., Tuzcu M., Ustundag B., Cikim G., Ozercan I. H., Sriramoju V., Juturu V., Komorowski J. R., Effect of chromium on carbohydrate and lipid metabolism in a rat model of type 2 diabetes mellitus: the fat-fed, streptozotocin-treated rat. Metabolism 2007 56 9 1233 1240 2-s2.0-34547811377 10.1016/j.metabol.2007.04.021 (Pubitemid 47225177)
17. Zhao S., Chu Y., Zhang C., Diet-induced central obesity and insulin resistance in rabbits. Journal of Animal Physiology and Animal Nutrition 2008 92 1 105 111
18. Bastaki S., Diabetes mellitus and its treatment. International Journal of Diabetes and Metabolism 2005 13 3 111 134 2-s2.0-33751249006 (Pubitemid 44783783)
19. Schier J. G., Hirsch O. N., Chu J., McLaughlin S., McKinney P., Crandall C., Octreotide as antidote for sulfonylurea-induced hypoglycemia. Annals of Emergency Medicine 2001 37 4 417 418 2-s2.0-0035046473
20. Nzerue C. M., Thomas J., Volcy J., Edeki T., Use of octreotide to treat prolonged sulfonylurea-induced hypoglycemia in a patient with chronic renal failure. International Journal of Artificial Organs 2003 26 1 86 89 2-s2.0-0041312587 (Pubitemid 36896254)
21. Amori R. E., Lau J., Pittas A. G., Efficacy and safety of incretin therapy in type 2 diabetes: systematic review and meta-analysis. Journal of the American Medical Association 2007 298 2 194 206 2-s2.0-34447267513 10.1001/jama.298.2.194 (Pubitemid 47057766)
22. International Diabetes Federation,. 2009, https://www.idf.org/latest- diabetes-figures-paint-grim-global-picture
23. Lü H., Chen J., Li W. L., Ren B. R., Wu J. L., Kang H. Y., Zhang H. Q., Adams A., De Kimpe N., Hypoglycemic and hypolipidemic effects of the total triterpene acid fraction from Folium Eriobotryae. Journal of Ethnopharmacology 2009 122 3 486 491 2-s2.0-63649128402 10.1016/j.jep.2009.01.030
24. Li W. L., Zheng H. C., Bukuru J., De Kimpe N., Natural medicines used in the traditional Chinese medical system for therapy of diabetes mellitus. Journal of Ethnopharmacology 2004 92 1 1 21 2-s2.0-1942424088 10.1016/j.jep.2003.12.031 (Pubitemid 38510258)
25. Ravi Kumar A., Ponnusamy S., Ravindran R., Zinjarde S., Bhargava S., Evaluation of traditional Indian antidiabetic medicinal plants for human pancreatic amylase inhibitory effect in vitro. Evidence-Based Complementary and Alternative Medicine 2011 2011 10 2-s2.0-78349299085 10.1155/2011/515647 515647
26. Malviya N., Jain S., Malviya S., Antidiabetic potential of medicinal plants. Acta Poloniae Pharmaceutica 2010 67 2 113 118 2-s2.0-77949418956
27. Jung S. H., Seol H. J., Jeon S. J., Son K. H., Lee J. R., Insulin-sensitizing activities of tanshinones, diterpene compounds of the root of Salvia miltiorrhiza Bunge. Phytomedicine 2009 16 4 327 335 2-s2.0-62549164227 10.1016/j.phymed.2008.12.017
28. Dheer R., Bhatnagar P., A study of the antidiabetic activity of Barleria prionitis Linn. Indian Journal of Pharmacology 2010 42 2 70 73 2-s2.0-77954221888 10.4103/0253-7613.64493
29. Randhir R., Shetty K., Mung beans processed by solid-state bioconversion improves phenolic content and functionality relevant for diabetes and ulcer management. Innovative Food Science and Emerging Technologies 2007 8 2 197 204 2-s2.0-34147095373 10.1016/j.ifset.2006.10.003 (Pubitemid 46561594)
30. Firdaus I. M., Nur Ashikin Psyquay A., Ghizan S., Maznah I., Anthesis and flower visitors in Curculigo latifolia Dryand. Journal of Biology and Life Sciences 2010 1 1 13 15
31. Chooi O. H., Tumbuhan Liar: khasiat Ubatan Dan Kegunaan Lain 2006 Kuala Lumpur, Malaysia Utusan Publications and Distributors Sendirian Berhad
32. Kant R., Sweet proteins-potential replacement for artificial low calorie sweeteners. Nutrition Journal 2005 4, article 5 2-s2.0-15744376671 10.1186/1475-2891-4-5 (Pubitemid 40418870)
33. Shimizu-Ibuka A., Morita Y., Terada T., Asakura T., Nakajima K. I., Iwata S., Misaka T., Sorimachi H., Arai S., Abe K., Crystal structure of neoculin: insights into its sweetness and taste-modifying activity. Journal of Molecular Biology 2006 359 1 148 158 2-s2.0-33646198782 10.1016/j.jmb.2006.03.030
34. Levin B. E., Hogan S., Sullivan A. C., Initiation and perpetuation of obesity and obesity resistance in rats. American Journal of Physiology 1989 256 3 766 771 2-s2.0-0024592902
35. Tuck M. K., Chan D. W., Chia D., Godwin A. K., Grizzle W. E., Krueger K. E., Rom W., Sanda M., Sorbara L., Stass S., Wang W., Brenner D. E., Standard operating procedures for serum and plasma collection: early detection research network consensus statement standard operating procedure integration working group. Journal of Proteome Research 2009 8 1 113 117 2-s2.0-60849109966 10.1021/pr800545q
36. Reuter T. Y., Diet-induced models for obesity and type 2 diabetes. Drug Discovery Today 2007 4 1 3 8 2-s2.0-37349095003 10.1016/j.ddmod.2007.09.004 (Pubitemid 350286528)
37. Warwick Z. S., Synowski S. J., Bell K. R., Dietary fat content affects energy intake and weight gain independent of diet caloric density in rats. Physiology and Behavior 2002 77 1 85 90 2-s2.0-0036711261 10.1016/S0031-9384(02) 00816-8 (Pubitemid 35245723)
38. Chatterjee M. N., Shinde R., Text Book of Medical Biochemistry 2002 Jaypee Brothers
39. Kumar N., Dey C. S., Metformin enhances insulin signalling in insulin-dependent and -independent pathways in insulin resistant muscle cells. British Journal of Pharmacology 2002 137 3 329 336 2-s2.0-0036791755 10.1038/sj.bjp.0704878
40. Rangachari B., Savarimuthu I., Antidiabetic and Hypolipidemic effect of methanol extract of Lippia nodiflora L. in streptozotocin induced diabetic rats. Asian Pacific Journal of Tropical Biomedicine 2011 1 1 30 36
41. Jouad H., Lemhadri A., Maghrani M., Zeggwagh N. A., Eddouks M., Cholesterol-lowering activity of the aqueous extract of Spergularia purpurea in normal and recent-onset diabetic rats. Journal of Ethnopharmacology 2003 87 1 43 49 2-s2.0-0038012720 10.1016/S0378-8741(03)00102-8 (Pubitemid 36644972)
42. Li Y., Wang P., Zhuang Y., Lin H., Li Y., Liu L., Meng Q., Cui T., Liu J., Li Z., Activation of AMPK by berberine promotes adiponectin multimerization in 3T3-L1 adipocytes. FEBS Letters 2011 585 12 1735 1740 2-s2.0-79958116611 10.1016/j.febslet.2011.04.051
43. Poitout V., Robertson R. P., Minireview: secondary β -cell failure in type 2 diabetes-a convergence of glucotoxicity and lipotoxicity. Endocrinology 2002 143 2 339 342 2-s2.0-0036153256 10.1210/en.143.2.339 (Pubitemid 34107184)
44. Bansal P., Paul P., Mudgal J., Nayak P. G., Thomas Pannakal S., Priyadarsini K. I., Unnikrishnan M. K., Antidiabetic, antihyperlipidemic and antioxidant effects of the flavonoid rich fraction of Pilea microphylla (L.) in high fat diet/streptozotocin-induced diabetes in mice. Experimental and Toxicologic Pathology 2012 64 651 658 2-s2.0-78650647730 10.1016/j.etp.2010.12. 009
45. Frojdo S., Durand C., Molin L., Carey A. L., El-Osta A., Kingwell B. A., Febbraio M. A., Solari F., Vidal H., Pirola L., Phosphoinositide 3-kinase as a novel functional target for the regulation of the insulin signaling pathway by SIRT1. Molecular and Cellular Endocrinology 2011 335 2 166 176
46. Lombardo Y. B., Chicco A. G., Effects of dietary polyunsaturated n-3 fatty acids on dyslipidemia and insulin resistance in rodents and humans. A review. Journal of Nutritional Biochemistry 2006 17 1 1 13 2-s2.0-28844485678 10.1016/j.jnutbio.2005.08.002 (Pubitemid 41774400)
47. Rossi A. S., Lombardo Y. B., Chicco A. G., Lipogenic enzyme activities and glucose uptake in fat tissue of dyslipemic, insulin-resistant rats: effects of fish oil. Nutrition 2010 26 2 209 217 2-s2.0-73649107296 10.1016/j.nut.2009. 04.006
48. Gomes A., Vedasiromoni J. R., Das M., Sharma R. M., Ganguly D. K., Anti-hyperglycemic effect of black tea (Camellia sinensis) in rat. Journal of Ethnopharmacology 1995 45 3 223 226 2-s2.0-0028907844 10.1016/0378-8741(95) 01223-Z
49. Shingo A. S., Kanabayashi T., Murasea T., Kito S., Cognitive decline in STZ-3V rats is largely due to dysfunctional insulin signaling through the dentate gyrus. Behavioural Brain Research 2012 229 9 378 383
50. Yang B., Chen L., Qian Y., Triantafillou J. A., McNulty J. A., Carrick K., Clifton L. G., Han B., Geske R., Strum J., Brown K. K., Stimpson S. A., Pahel G., Changes of skeletal muscle adiponectin content in diet-induced insulin resistant rats. Biochemical and Biophysical Research Communications 2006 341 1 209 217 2-s2.0-30944449424 10.1016/j.bbrc.2005.12.172 (Pubitemid 43117406)
51. Bolkent S., Yanardag R., Bolkent S., Döger M. M., Beneficial effects of combined treatment with niacin and chromium on the liver of hyperlipemic rats. Biological Trace Element Research 2004 101 3 219 229 2-s2.0-10044257464 10.1385/BTER:101:3:219 (Pubitemid 39612055)
52. Sugano M., Yamato H., Hayashi T., Ochiai H., Kakuchi J., Goto S., Nishijima F., Iino N., Kazama J. J., Takeuchi T., Mokuda O., Ishikawa T., Okazaki R., High-fat diet in low-dose-streptozotocin-treated heminephrectomized rats induces all features of human type 2 diabetic nephropathy: a new rat model of diabetic nephropathy. Nutrition, Metabolism and Cardiovascular Diseases 2006 16 7 477 484 2-s2.0-33749053166 10.1016/j.numecd.2005.08.007 (Pubitemid 44466387)
53. Rakhshandehroo M., Knoch B., Müller M., Kersten S., Peroxisome proliferator-activated receptor alpha target genes. PPAR Research 2010 2010 20 2-s2.0-78349283454 10.1155/2010/612089 612089
54. Rhodes C. J., White M. F., Molecular insights into insulin action and secretion. European Journal of Clinical Investigation 2002 32 3 3 13 2-s2.0-0036615436 (Pubitemid 41704995)
55. Palsgaard J., Brown A. E., Jensen M., Borup R., Walker M., De Meyts P., Insulin-like growth factor I (IGF-I) is a more potent regulator of gene expression than insulin in primary human myoblasts and myotubes. Growth Hormone and IGF Research 2009 19 2 168 178 2-s2.0-61649096363 10.1016/j.ghir.2008.09.004
56. Teppala S., Shankar A., Association between serum IGF-1 and diabetes among U.S. adults. Diabetes Care 2010 33 10 2257 2259 2-s2.0-79951708410 10.2337/dc10-0770
57. Wang Y., Zhang D., Liu Y., Yang Y., Zhao T., Xu J., Li S., Zhang Z., Feng G., He L., Xu H., Association study of the single nucleotide polymorphisms in adiponectin-associated genes with type 2 diabetes in Han Chinese. Journal of Genetics and Genomics 2009 36 7 417 423 2-s2.0-67650976552 10.1016/S1673- 8527(08)60131-9
58. Petersson U., Östgren C. J., Brudin L., Brismar K., Nilsson P. M., Low levels of insulin-like growth-factor-binding protein-1 (IGFBP-1) are prospectively associated with the incidence of type 2 diabetes and impaired glucose tolerance (IGT): The Söderåkra Cardiovascular Risk Factor Study. Diabetes and Metabolism 2009 35 3 198 205 2-s2.0-67349108377 10.1016/j.diabet.2008.11.003
59. Pita J., Panadero A., Soriano-Guillén L., Rodríguez E., Rovira A., The insulin sensitizing effects of PPAR- γ agonist are associated to changes in adiponectin index and adiponectin receptors in Zucker fatty rats. Regulatory Peptides 2012 174 7 18 25
60. Kuroda M., Mimaki Y., Honda S., Tanaka H., Yokota S., Mae T., Phenolics from Glycyrrhiza glabra roots and their PPAR- γ ligand-binding activity. Bioorganic and Medicinal Chemistry 2010 18 2 962 970 2-s2.0-76449109205 10.1016/j.bmc.2009.11.027
61. Kadowaki T., Yamauchi T., Adiponectin and adiponectin receptors. Endocrine Reviews 2005 26 3 439 451 2-s2.0-18844432308 10.1210/er.2005-0005 (Pubitemid 40686653)
62. Gross B., Staels B., PPAR agonists: multimodal drugs for the treatment of type-2 diabetes. Best Practice and Research in Clinical Endocrinology and Metabolism 2007 21 4 687 710 2-s2.0-36549038966 10.1016/j.beem.2007.09.004 (Pubitemid 350177568)
63. Lalloyer F., Vandewalle B., Percevault F., Torpier G., Kerr-Conte J., Oosterveer M., Paumelle R., Fruchart J. C., Kuipers F., Pattou F., Fiévet C., Staels B., Peroxisome proliferator-activated receptor α improves pancreatic adaptation to insulin resistance in obese mice and reduces lipotoxicity in human islets. Diabetes 2006 55 6 1605 1613 2-s2.0-33748291464 10.2337/db06-0016 (Pubitemid 44324112)
64. Staels B., Fruchart J. C., Therapeutic roles of peroxisome proliferator-activated receptor agonists. Diabetes 2005 54 8 2460 2470 2-s2.0-23644456172 10.2337/diabetes.54.8.2460 (Pubitemid 41134276)
65. Ravnskjaer K., Boergesen M., Rubi B., Larsen J. K., Nielsen T., Fridriksson J., Maechler P., Mandrup S., Peroxisome proliferator-activated receptor α (PPAR α) potentiates, whereas PPAR γ attenuates, glucose-stimulated insulin secretion in pancreatic β -cells. Endocrinology 2005 146 8 3266 3276 2-s2.0-23044478417 10.1210/en.2004-1430 (Pubitemid 41058096)
66. Hajer G. R., Van Haeften T. W., Visseren F. L. J., Adipose tissue dysfunction in obesity, diabetes, and vascular diseases. European Heart Journal 2008 29 24 2959 2971 2-s2.0-58049219012 10.1093/eurheartj/ehn387